Last: | $126.69 |
---|---|
Change Percent: | -0.17% |
Open: | $127.51 |
Close: | $126.69 |
High: | $128.43 |
Low: | $126.62 |
Volume: | 3,250,142 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$126.69 | $127.51 | $126.69 | $128.43 | $126.62 | 3,250,142 | 05-08-2024 |
$127.29 | $126.65 | $127.29 | $127.8 | $126.38 | 4,167,492 | 05-07-2024 |
$124.59 | $122 | $124.59 | $124.64 | $121.78 | 3,636,591 | 05-06-2024 |
$123.05 | $122.92 | $123.05 | $123.77 | $121.2902 | 5,932,926 | 05-03-2024 |
$124.02 | $127.94 | $124.02 | $127.94 | $123.83 | 8,487,072 | 05-02-2024 |
$129.21 | $127.8 | $129.21 | $130.13 | $127.5 | 5,217,688 | 05-01-2024 |
$128.31 | $128.05 | $128.31 | $130.4631 | $127.49 | 7,587,769 | 04-30-2024 |
$126.88 | $127.32 | $126.88 | $127.97 | $126.52 | 1,874,519 | 04-29-2024 |
$126.85 | $126.15 | $126.85 | $127.9 | $125.99 | 3,312,457 | 04-26-2024 |
$125.79 | $123.69 | $125.79 | $125.85 | $123.2096 | 3,394,198 | 04-25-2024 |
$126.16 | $127.16 | $126.16 | $127.32 | $125.35 | 3,092,009 | 04-24-2024 |
$128.64 | $126.57 | $128.64 | $128.76 | $126.34 | 3,703,606 | 04-23-2024 |
$125.26 | $122.59 | $125.26 | $126.25 | $122.57 | 3,798,340 | 04-22-2024 |
$122.71 | $123.48 | $122.71 | $124.54 | $122.46 | 5,183,469 | 04-19-2024 |
$122.75 | $123.3 | $122.75 | $124.095 | $122.51 | 2,841,036 | 04-18-2024 |
$124.53 | $124.95 | $124.53 | $125.21 | $123.26 | 3,075,118 | 04-17-2024 |
$123.45 | $123.07 | $123.45 | $124.2505 | $121.79 | 3,044,113 | 04-16-2024 |
$123.9 | $125.81 | $123.9 | $126.05 | $123.52 | 2,896,694 | 04-15-2024 |
$124.51 | $126.74 | $124.51 | $127.06 | $124.35 | 3,343,015 | 04-12-2024 |
$125.4 | $125.48 | $125.4 | $125.88 | $124.13 | 2,418,961 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
Tesla and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving his...
2024-05-03 07:00:00 ET Novo Nordisk 's (NYSE: NVO) success hinges on two key products: Ozempic and Wegovy. The former is a diabetes treatment, while the latter is its fast-growing weight-loss drug. Both are comparable and have been associated with helping people lose significant bod...
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and&n...